Targeting ELTD1, an angiogenesis marker for glioblastoma (GBM), also affects VEGFR2: molecular-targeted MRI assessment

Glioblastomas (GBM) are deadly brain tumors that currently do not have long-term patient treatments available. GBM overexpress the angiogenesis factor VEGF and its receptor VEGFR2. ETLD1 (epidermal growth factor, latrophilin and seven transmembrane domain-containing protein 1), a G-protein coupled r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Nucl Med Mol Imaging
Autors principals: Ziegler, Jadith, Zalles, Michelle, Smith, Nataliya, Saunders, Debra, Lerner, Megan, Fung, Kar-Ming, Patel, Maulin, Wren, Jonathan D, Lupu, Florea, Battiste, James, Towner, Rheal A
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6420708/
https://ncbi.nlm.nih.gov/pubmed/30911439
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars